G
GI Innovation Inc
KOSDAQ:358570
GI Innovation Inc
KOSDAQ:358570
Price:
15 290
KRW
-0.71%
Market Cap:
₩976.6B
GI Innovation Inc
Other Items
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
GI Innovation Inc
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
GI Innovation Inc
KOSDAQ:358570
|
Other Items
₩15.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Other Items
-₩14.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Other Items
₩225.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other Items
₩23.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other Items
-₩202.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-26%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other Items
₩3.1B
|
CAGR 3-Years
-46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
GI Innovation Inc
Glance View
GI Innovation, Inc. engages in the development of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 88 full-time employees. The company went IPO on 2023-03-30. The firm is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Intrinsic Value
104.56
KRW
Overvaluation 99%
G
See Also
What is GI Innovation Inc's Other Items?
Other Items
15.3B
KRW
15.3B
KRW
Based on the financial report for Dec 31, 2024, GI Innovation Inc's Other Items amounts to 15.3B KRW.
What is GI Innovation Inc's Other Items growth rate?
Other Items CAGR 1Y
-33%
-33%
Over the last year, the Other Items growth was -33%.
